Abstract
COVID-19 has pushed us to think differently about health and its delivery, and following the declaration of pandemic by the World Health Organization (WHO), value chains have been largely broken and must be rebuilt and redesigned. COVID-19 brought the whole world to a standstill, and its impact on overall healthcare utilization and cost trends is undeniable; as such, the importance of public health expertise and health economics outcomes research (HEOR) to support and inform public health cannot be overstated. The virtual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting brought together experts and leaders in the HEOR field to explore topics that will shape healthcare decision making over the coming decades and to consider the useful lessons learnt from COVID-19 and how these will impact healthcare decisions in the post-COVID-19 era.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
